A solution containing polyclonal antibodies, created by injecting animals with human lymphocytes, which is used as a nonspecific immunosuppressant in the treatment of transplant rejection. Because it is polyclonal, ALG is active against many antigens; in contrast, monoclonal antibodies act against one specific antigen only.